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n	 INTRODUCTION
Systemic sclerosis (SSc) is a connective tissue disease characterized by func-
tional lesions and damage of the microcir-
culation, with alterations of the immune 
response and activation of fibroblast func-
tion, resulting in fibrosis in the skin and 
internal organs.
Pulmonary arterial hypertension (PAH) is 
one of the most severe visceral manifesta-
tions of SSc. It is a major cause of mortal-
ity in SSc patients, mainly in those affected 
by the limited cutaneous form (lcSSc) and 
with a long disease duration (1).
Before the introduction of specific treat-
ment, the survival rate after 1 year from the 
diagnosis of PAH was approximately 45%, 
whereas it is estimated that the 3-year sur-
vival rate is around 60% (2).
The increase of pulmonary artery pressure 
(PAP) is due to an increase in pulmonary 
vascular resistance. The main pathogenetic 
mechanisms are dysregulation of endothe-
lial cells, vasoconstriction, vascular wall 
remodelling and in situ thrombosis. En-
dothelial dysfunction is caused by both 
biochemical changes (hypoxia, acidosis, 
inflammatory mediators) and mechanical 
abnormalities (increased tension on the 
vessel walls) (3).
Another visceral manifestation in SSc pa-
tients is cardiac involvement, which is often 
clinically hidden. When it becomes clini-
SUMMARY
The impairment of the right ventricle (RV) in systemic sclerosis (SSc) is usually related to pulmonary arterial 
hypertension (PAH). New echocardiographic techniques, such as 3-dimensional echocardiography (3DE) and 
2-dimensional speckle tracking (2DSTE), allow an accurate evaluation of the RV function. The aim of this 
study was to evaluate the RV function using 3DE and 2DSTE in SSc patients with no history of heart disease 
and no PAH. 
Forty-five SSc patients, 42 females and 3 males, 28 with limited cutaneous SSc (lcSSc) and 17 with diffuse 
cutaneous SSc (dcSSc), were studied. Forty-three age- and gender-matched healthy subjects were enrolled as 
controls. All of them underwent a 3DE and 2DSTE ecocardiographic evaluation of the RV function. Systolic 
pulmonary arterial pressure (sPAP) and total pulmonary vascular resistance (tPVR) were also estimated by 
power doppler. RV echocardiographic parameters were compared in the different subsets of SSc patients. A 
statistical analysis was performed by t-test, ANOVA and multiple logistic regression.
RV areas in 2DSTE and volumes in 3DE were higher and RV function parameters were reduced in SSc patients 
compared with controls. Also sPAP and tVPR were higher, but they did not reach pathological values. Echocar-
diographic alterations were more pronounced in patients with lcSSc. 
3DE and 2DSTE echocardiography allowed us to detect morphological and functional alterations of the RV 
in a group of SSc patients with no clinical signs of heart disease and no PAH. These patients had significantly 
higher sPAP and tPVR than healthy controls without reporting values compatible with PAH. These data suggest 
that RV alterations are related to a pressure overload rather than to an intrinsic myocardial involvement in SSc.
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cally evident, it is regarded as a poor prog-
nostic factor and actually causes about 20% 
of deaths attributed to this disease (4, 5).
It can involve all cardiac structures (endo-
cardium, myocardium and pericardium) 
and may result in pericardial effusion, ven-
tricular arrhythmias, conduction system 
defects, myocardial ischemia and heart 
failure. The functional and structural vas-
cular impairment affecting the microcir-
culation seems to be the cause of repeated 
focal ischemia resulting into irreversible 
myocardial fibrosis (6).
Right ventricular (RV) involvement in SSc 
is usually related to the onset of pulmonary 
hypertension (PH). However it is still un-
clear whether SSc can directly affect the 
RV function in absence of PH.
Ventricular diastolic dysfunction is a sign 
of myocardial involvement in SSc (7). The 
methods generally used to detect cardiac 
involvement make it possible to identify 
myocardial abnormalities only at an ad-
vanced stage, when the organ damage has 
already occured.
Recently, the introduction of new more 
accurate echocardiographic techniques, 
such as 3-dimensional echocardiography 
(3DE) and 2-dimensional speckle tracking 
(2DSTE), has allowed a better assessment 
of the RV function and myocardial me-
chanics (8-10). In particular, the 3DE has 
proved to be accurate, sensitive and repro-
ducible in the assessment of Vdx (11, 12).
The 2DSTE is an echocardiographic tech-
nique aimed to assess the systolic function 
of the left ventricle (LV). Recent studies 
have demonstrated its validity also in the 
assessment of the RV function (13).
The aim of this study was to use 3DE and 
2DSTE in SSc patients to identify early 
echo markers of RV impairment, in the ab-
sence of PH.
n	 MATERIALS AND METHODS
Forty-five patients attending the outpatient 
clinic of the Rheumatology Unit of Padova 
University Hospital were recruited. Inclu-
sion criteria of this study consisted of a 
definite diagnosis of SSc according to the 
American College of Rheumatology/Euro-
pean League against Rheumatism (ACR/
EULAR) classification (14), the absence of 
signs and symptoms of heart disease and 
no evidence of PAH in the standard echo-
cardiography.
We enrolled forty-five SSc patients (42 fe-
male and 3 male) with a mean age of 56±13 
years and mean SSc duration of 13.6±9.4 
years.
Twenty-eight patients were affected by the 
limited form, while 17 by the diffuse cuta-
neous subset (dcSSc) of SSc. Antinuclear 
antibodies (ANA) were positive in all pa-
tients, with anti-centromere (ACA) speci-
ficity in 15 cases, anti-Scl-70 in 17 and 
without specific ANA in 13. 
Forty-three age- and gender-matched 
healthy subjects were enrolled as controls.
All patients underwent transthoracic echo-
cardiography with a Vivid E9 ultrasound 
scanner (GE Medical Systems, Horten, 
Norway) with MS5 and V4 probes. Images 
were captured both in the two-dimension-
al (2D) and Doppler modes using a M5S 
probe by parasternal, apical and subcostal 
approaches, and both volumetric 3D data-
sets of the four chambers of the heart with 
the apical approach in full-volume, the sum 
the partial volumes of 4-6 cycles consecu-
tive cardiac, acquired in apnea.
For 2D images, three consecutive cardiac 
cycles were recorded in digital format and 
analyzed using the EchoPAC software 
(GE Medical Systems). 3D images were 
analyzed using the EchoPAC software (GE 
Medical Systems) and the 4D RV function 
(TomTec Imaging Systems, GmbH, Unter-
schleissheim, Germany). Particular atten-
tion was devoted to the assessment of the 
right ventricular 2DSTE. The longitudinal 
strain was measured in the apical section 4 
rooms modified for Vdx. Both the global 
longitudinal strain, including the inter-
ventricular septum, and the longitudinal 
strain of the single free wall of Vdx were 
obtained.
All values observed were compared in the 
different cutaneous form of SSc and in the 
different antibody specificities.
A statistical analysis was performed us-
ing SPSS 18.0 for Windows (SPSS, Chi-
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cago, IL, USA) and MedCalc for Windows 
8.1.1.0 (Mariakerke, Belgium). Continuous 
variables with normal distribution were ex-
pressed as mean ± SD. The t-test, ANOVA 
and multiple logistic regression were used 
to compare patients and controls. A prob-
ability of less than 5% was considered sig-
nificant.
n	 RESULTS
The clinical and anthropometric character-
istics of the SSc patients studied and the 
control subjects are summarized in Table I. 
Anthropometric data were similar, where-
as the heart rate and the blood pressure 
showed a statistically significant differ-
ence, with higher values in the scleroderma 
patients. 
The multiple logistic regression considered 
in the same model the three main variables 
measured in echocardiography and a cor-
relation was found between SSc patients 
and control subjects: heart rate (P=0.0003), 
systolic blood pressure (P=0.002), diastolic 
blood pressure (P=0.048). 
Table II reports the echocardiographic 
measurements of the RV. 
Patients showed a significant increase of 
the RV size and a significant reduction 
of its contractile function as compared to 
controls in 2D-echocardiography. Longitu-
dinal strain was similar in the two groups. 
A three-dimensional evaluation confirmed 
the increased size and reduced ejection 
fraction in patients with scleroderma. Dop-
pler parameters showed higher values of 
systolic pulmonary pressure (sPAP) and 
pulmonary vascular resistance (tPVR) in 
scleroderma patients compared to healthy 
controls, despite they did not reach patho-
logical values (Table II).
The comparison between the echocardio-
graphic parameters in patients with differ-
ent clinical subsets (Tab. III) showed an in-
crease RV size in the dcSSc than the lcSSc, 
with a nonsignificant reduction of con-
tractile function. The values of sPAP and 
Table III - Right ventricular echocardiographic parameters in different subsets 
of systemic sclerosis.
lcSSc
N=28
dcSSc
N=17
P
Two-dimensional parameters
End-diastolic area, cm2 20.5±5 18±3 n.s.
End-systolic area, cm2 11±3 9±3 0.045
Fractional area change, % 45±7 49±8 n.s.
TAPSE, mm 23±3 23±3 n.s.
S Wave TDI, cm/s 12±1 13±2 n.s.
Global longitudinal strain 2D, % -25.5±3 -25.2±3 n.s.
Free wall longitudinal strain 2D, % -29.6±4 -31±5 n.s.
Three-dimensional parameters
End-diastolic volume 3D, mL 106±28 85±21 0.016
End-systolic volume 3D, mL 55±18 43±12 0.018
Ejection fraction 3D, % 48±7 50±5 n.s.
Doppler parameters
Pulmonary artery systolic pressure, mmHg 33±10 30±11 n.s.
Pulmonary vascular resistance, WU 1.7±0.7 1.6±0.3 n.s.
lcSSc, limited cutaneous systemic sclerosis; dcSSc, diffuse cutaneous SSc; 
n.s., not significant.
Table II - Echocardiographic parameters of right ventricle.
Patients
N=45
Controls
N=43
P
Two-dimensional parameters
End-diastolic area, cm2 19±4 17±3 0.002
End-systolic area, cm2 10±3.5 8±1.5 <0.0001
Fractional area change, % 47±8 52±6 0.002
TAPSE, mm 23±3 26±2 <0.0001
S Wave TDI, cm/s 12±2 15±3 <0.0001
Global longitudinal strain 2D, % -24.8±4 -25.6±3 n.s.
Free wall longitudinal strain 2D, % -30±5 -31.3±4 n.s.
Three-dimensional parameters
End-diastolic volume 3D, mL 97±28 87±17 0.049
End-systolic volume 3D, mL 50±18 34±8 <0.0001
Ejection fraction 3D, % 49±6 61±6 <0.0001
Doppler parameters
Pulmonary artery systolic pressure, mmHg 33±14 22±5 <0.0001
Pulmonary vascular resistance, WU 1.9±0.6 1.4±0.3 0.001
n.s., not significant.
Table I - Anthropometric and clinical characteri-
stics.
Patients
N=45
Controls
N=43
P
Weight, kg 64±11 63±7 n.s.
Height, cm 163±7 164±7 n.s.
Heart rate/min 76±12 66±12 <0.0001
Systolic blood 
pressure, mmHg
134±21 120±21 0.002
Diastolic blood 
pressure, mmHg
78±9 74±7 0.035
n.s., not significant.
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tPVR were higher in patients affected with 
lcSSc, without reaching statistical signifi-
cance. The echocardiographic parameters 
showed no significant difference in the pa-
tients with specific (ACA and Scl-70) and 
aspecific ANA.
n	 DISCUSSION  
 AND CONCLUSIONS
The study was conducted in a series of 
scleroderma patients with typical demo-
graphic characteristics: prevalence of fe-
males, average age of onset between 40 
and 45 years, prevalent lcSSc, specific anti-
centromere antibody more frequently than 
the dcSSc.
We recruited patients with no symptoms or 
signs of heart disease or standard echocar-
diographic evidence of PAH. 
The main aim of the study was an echocar-
diographic assessment of the RV. 
We used highly sensitive methods capable 
of providing details of 2D images to evalu-
ate the global longitudinal strain and the 
free wall of the RV. We took 3D images for 
a more accurate measurement of volumes 
and ejection fraction of the ventricle itself 
and power Doppler image to estimate sPAP 
and tPVR.
Our data showed that the RV in sclero-
derma patients had a higher end-diastolic 
and systolic volume and a reduced ejection 
fraction compared with healthy controls. 
These morphological and functional al-
terations are not significant enough to 
cause clinical symptoms or signs, although 
conceivably stress tolerance is reduced. It 
should be emphasized that many sclero-
derma patients are not able to make any 
physical effort due to skin lesions, muscu-
loskeletal disorders and frequent concomi-
tant pulmonary fibrosis.
Power Doppler has shown that the sPAP 
values and tPVR were significantly higher 
in SSc patients than in healthy controls, al-
though they did not reach values compatible 
with PAH. This observation may explain the 
alterations of the RV, probably secondary to 
the pressure overload and not to the damage 
caused by the intrinsic cardiomyopathy, be-
cause the strain values were comparable to 
those of healthy subjects.
Our data suggest that scleroderma patients 
without pulmonary hypertension have prob-
ably an obliterative vasculopathy which in-
creases the resistance and pulmonary artery 
pressure.
These changes were more significant in the 
subset of patients with lcSSc. It is no coin-
cidence that these subsets have developed 
PAH after many years.
In literature, only a few works have been 
published on the echocardiographic assess-
ment of myocardial strain and 3D-echocar-
diography applied to SSc. Most of these 
were dedicated to a morphological and 
functional analysis of the LV.
These studies showed that the assessment 
of the myocardial function through the use 
of the echocardiographic speckle tracking 
strain was able to detect alterations in the 
function of Vsx in SSc patients, in the ab-
sence of symptoms related to myocardial 
dysfunction and with a preserved ejection 
fraction (15-18).
Only three authors studied the Vdx in SSc 
using the 2DSTE and their data are in 
line with those of our study (19-21). They 
showed how the systolic dysfunction of the 
Vdx may precede the onset of the increase 
in the sPAP values and reflect the adapta-
tion of the myocardium to the obliterative 
vasculopathy that characterizes SSc.
The use of the 2DSTE echocardiographic 
method is useful to detect early functional 
changes in the Vdx in patients with SSc. It 
should be emphasized that a repeat echo-
cardiogram with Doppler during the fol-
low-up is very important to detect early 
myocardial alterations and to monitor the 
values of the pulmonary artery pressure 
(22, 23).
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